immune system
• Both CD4- and CD8- T cells proliferate poorly in culture to ConA, anti-CD3 treatment, or anti-CD3 + anti-CD28 treatment
• T cells also have reduced proliferation in response to allogenic MHC
• proliferation defects are intrinsic to T cells as revealed by bone marrow chimeras
• T cells proliferate normally to PMA + ionomycin treatment
|
• thymoyctes proliferate poorly in culture to ConA, anti-CD3 treatment, or anti-CD3 + anti-CD28 treatment
|
• NK cells produce very little IFN-gamma when stimulated in culture
|
• thymocytes secrete 2- to 3- fold less IFN-gamma when stimulated in vitro
• CD8 T cells produce very little IFN-gamma when stimulated in vitro
CD8 T cells produce very little IFN-gamma when stimulated in vitro
|
• thymocytes secrete 2- to 3- fold less IL-2 when stimulated in vitro
• CD8 T cells produce virtually no IL-2 when stimulated in vitro
|
hematopoietic system
• Both CD4- and CD8- T cells proliferate poorly in culture to ConA, anti-CD3 treatment, or anti-CD3 + anti-CD28 treatment
• T cells also have reduced proliferation in response to allogenic MHC
• proliferation defects are intrinsic to T cells as revealed by bone marrow chimeras
• T cells proliferate normally to PMA + ionomycin treatment
|
• thymoyctes proliferate poorly in culture to ConA, anti-CD3 treatment, or anti-CD3 + anti-CD28 treatment
|
• NK cells produce very little IFN-gamma when stimulated in culture
|
endocrine/exocrine glands
• thymoyctes proliferate poorly in culture to ConA, anti-CD3 treatment, or anti-CD3 + anti-CD28 treatment
|
cellular
• Both CD4- and CD8- T cells proliferate poorly in culture to ConA, anti-CD3 treatment, or anti-CD3 + anti-CD28 treatment
• T cells also have reduced proliferation in response to allogenic MHC
• proliferation defects are intrinsic to T cells as revealed by bone marrow chimeras
• T cells proliferate normally to PMA + ionomycin treatment
|